News
Sunshine Heart Completes Training for US Feasibility Trial
ASX-listed heart device maker Sunshine Heart has finished training clinicians at six US hospitals ahead of its C-Pulse feasibility trial, planned to start later in 2007.
Company
Chicago, OS
Every investor coverage indicates participated in a round Northwestern University Feinberg School of Medicine raised.
Companies Northwestern University Feinberg School of Medicine acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Northwestern University Feinberg School of Medicine. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed heart device maker Sunshine Heart has finished training clinicians at six US hospitals ahead of its C-Pulse feasibility trial, planned to start later in 2007.